Biomea Fusion, Inc. (BMEA) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $1.36 (+0.37%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Oct 31, 2024 | Joseph Catanzaro | Piper Sandler | $19.00 | +1291.9% |
| Oct 30, 2024 | Peter Lawson | Barclays | $11.00 | +705.9% |
| Oct 22, 2024 | Joseph Pantginis | H.C. Wainwright | $40.00 | +2830.4% |
| Sep 27, 2024 | Joseph Catanzaro | Piper Sandler | $10.00 | +632.6% |
| Jun 7, 2024 | Joseph Pantginis | H.C. Wainwright | $15.00 | +998.9% |
| Jun 7, 2024 | George Farmer | Scotiabank | $21.00 | +1438.5% |
| Jun 7, 2024 | Peter Lawson | Barclays | $5.00 | +266.3% |
| Jun 14, 2022 | Joseph Pantginis | H.C. Wainwright | $16.00 | +1072.2% |
Top Analysts Covering BMEA
BMEA vs Sector & Market
| Metric | BMEA | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 7 | 8 | 18 |
| Target Upside | +1379.8% | +1148.5% | +14.9% |
| P/E Ratio | -1.79 | 6.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3M | $3M | $3M | 6 |
| 2027-12-31 | $1M | $1M | $1M | 7 |
| 2028-12-31 | $5M | $5M | $5M | 5 |
| 2029-12-31 | $616M | $616M | $616M | 2 |
| 2030-12-31 | $107M | $107M | $107M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-1.38 | $-0.94 | $-0.59 | 5 |
| 2027-12-31 | $-2.45 | $-1.22 | $-0.60 | 5 |
| 2028-12-31 | $-1.19 | $-0.90 | $-0.75 | 4 |
| 2029-12-31 | $-1.02 | $-1.02 | $-1.02 | 2 |
| 2030-12-31 | $-0.08 | $-0.08 | $-0.08 | 2 |
Frequently Asked Questions
What is the analyst consensus for BMEA?
The consensus among 7 analysts covering Biomea Fusion, Inc. (BMEA) is Buy with an average price target of $20.20.
What is the highest price target for BMEA?
The highest price target for BMEA is $40.00, set by Joseph Pantginis at H.C. Wainwright on 2024-10-22.
What is the lowest price target for BMEA?
The lowest price target for BMEA is $5.00, set by Peter Lawson at Barclays on 2024-06-07.
How many analysts cover BMEA?
7 analysts have issued ratings for Biomea Fusion, Inc. in the past 12 months.
Is BMEA a buy or sell right now?
Based on 7 analyst ratings, BMEA has a consensus rating of Buy (2.00/5) with a +1379.8% upside to the consensus target of $20.20.
What are the earnings estimates for BMEA?
Analysts estimate BMEA will report EPS of $-0.94 for the period ending 2026-12-31, with revenue estimated at $3M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.